CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
Not yet recruiting · NCT06617286 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma | classic Hodgkin lymphoma | Not yet recruiting | Phase 1 / Phase 2 | 2026-04-15 | NCT06617286 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| New York Medical College | 28 |
| University of North Carolina | 30 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| New York Medical College | Valhalla | United States | 71 |